Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News
FDA approves citrate-free, high concentration formulation of Humira biosimilar
The FDA has approved a citrate-free, 100 mg/mL formulation of the Humira biosimilar Hadlima, according to a statement released by Samsung Bioepis and Organon.
Better use of cytokine signalizing could ‘revolutionize’ rheumatology treatment
Correctly identifying cytokine pathways that are dysregulated in any given rheumatology patient could lead to better use of current biologic therapies, said a presenter at the 2022 Association of Women in Rheumatology annual conference.
Log in or Sign up for Free to view tailored content for your specialty!
Head-to-head studies ‘would be nice’: More data needed to ascertain JAK inhibitor risks
More trials are needed to fully elucidate the cardiovascular, infection and malignancy risks linked to Janus kinase inhibitors in rheumatoid arthritis, said a presenter at the 2022 Association of Women in Rheumatology annual conference.
TYK2 inhibitors may offer pathway for more comprehensive inflammation therapy
The emergence of drugs inhibiting the JAK-STAT pathway has culminated in tyrosine kinase 2 inhibitors targeting psoriatic arthritis, lupus and other indications, noted a presenter at the 2022 Association of Women in Rheumatology conference.
Scorpion venom mini-proteins in RA treatment
The next new treatment for rheumatoid arthritis could come from the unlikeliest of sources. Researchers based at Seattle Children’s Hospital spent the last several years studying the potential use of mini-proteins found in scorpion venom toxin — not to poison, but to help heal.
Systemic inflammation in psoriasis accelerates CVD risk
LOUISVILLE, Ky. — Persistent, chronic inflammation seen in moderate to severe psoriasis is associated with plaque destabilization and rupture that drives MI, and biologic treatment can reduce CV risk, according to a speaker.
Medical cannabis growing in acceptance, improves pain in several rheumatic diseases
ORLANDO — Medical cannabis is growing in acceptance and has benefits for managing pain in patients with rheumatic diseases, but more research is required, a presenter said at the 2022 Rheumatology Nurses Society Conference.
Microbiome can influence autoimmune diseases such as rheumatoid arthritis, IBD
ORLANDO — Altered gut flora has the potential to impact autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease, noted a speaker at the 2022 Rheumatology Nurses Society Conference.
Lifestyle changes may minimize ‘inflammatory cascade’ associated with autoimmune disease
ORLANDO — Lifestyle modifications such as exercise and an anti-inflammatory diet can improve the well-being of patients being treated for autoimmune diseases, said a presenter at the 2022 Rheumatology Nurses Society Conference.
Different types of arthritis ‘present very differently’ in synovium, synovial fluid
ORLANDO — Understanding the nature and role of the synovium and synovial fluid is critical to managing various types of arthritis, according to a presenter at the 2022 Rheumatology Nurses Society Annual Conference.
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read
-
Headline News
Q&A: Oral injuries could be signs of abuse, neglect
September 04, 20245 min read -
Headline News
Providing menstrual products in schools ‘critical step’ to address period poverty
September 04, 20243 min read -
Headline News
Access to care, education may improve early introduction of allergens into infant diets
September 05, 20247 min read